AstonK, RathN, NaikA, and SlomczynskaU. Computer-aided design (CAD) of Mn (II) complexes: Superoxide dismutase mimetics with catalytic activity exceeding the native enzyme. Inorg Chem, 40: 1779–1789, 2001.
2.
Batinic-HaberleI, TovmasyanA, and SpasojevicI. An educational overview of the chemistry, biochemistry and therapeutic aspects of Mn porphyrins – From superoxide dismutation to H2O2-driven pathways. Redox Biol, 5: 43–65, 2015.
3.
Batinic-HaberleI, TovmasyanA, and SpasojevicI. Antioxidants in translation medicine–Commentary. Antioxid Redox Signal, 24: 518–524, 2016.
4.
EvansMK, TovmasyanA, Batinic-HaberleI, and DeviGR. Mn porphyrin in combination with ascorbate acts as a pro-oxidant and mediates caspase-independent cancer cell death. Free Radic Biol Med, 68: 302–314, 2014.
5.
RobbinsD and ZhaoY. Manganese superoxide dismutase in cancer prevention. Antioxid Redox Signal, 20: 1628–1645, 2014.
6.
SalveminiD and RileyDP. Nonpeptidyl mimetics of superoxide dismutase in clinical therapies for diseases. Cell Mol Life Sci, 57: 1489–1492, 2000.
7.
SchmidtHHHW, StockerR, VollbrachtC, PaulsenG, RileyD, DaiberA, and CuadradoA. Antioxidants in translational medicine. Antioxid Redox Signal, 23: 1130–1143, 2015.
8.
ValezV, CassinaA, Batinic-HaberleI, KalyanaramanBB, Ferrer-SuetaG, and RadiR. Peroxynitrite formation in nitric oxide-exposed submitochondrial particles: Detection, oxidative damage and catalytic removal by Mn-porphyrins. Arch Biochem Biophys, 529: 45–54, 2013.
